| Nanoparticle delivery systems in cancer vaccines Y Krishnamachari, SM Geary, CD Lemke, AK Salem Pharmaceutical research 28, 215-236, 2011 | 279 | 2011 |
| Development of pH-and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon Y Krishnamachari, P Madan, S Lin International journal of pharmaceutics 338 (1-2), 238-247, 2007 | 200 | 2007 |
| Innovative strategies for co-delivering antigens and CpG oligonucleotides Y Krishnamachari, AK Salem Advanced drug delivery reviews 61 (3), 205-217, 2009 | 194 | 2009 |
| Self‐Assembly of Cell–Microparticle Hybrids Y Krishnamachari, ME Pearce, AK Salem Advanced materials 20 (5), 989-993, 2008 | 40 | 2008 |
| Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic … L Hong, Y Krishnamachari, D Seabold, V Joshi, G Schneider, AK Salem Tissue Engineering Part C: Methods 17 (3), 319-325, 2011 | 39 | 2011 |
| Efficacy of polymeric encapsulated C5a peptidase–based group B streptococcus vaccines in a murine model DA Santillan, KK Rai, MK Santillan, Y Krishnamachari, AK Salem, ... American journal of obstetrics and gynecology 205 (3), 249. e1-249. e8, 2011 | 35 | 2011 |
| Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human … L Hong, N Wei, V Joshi, Y Yu, NJ Kim, Y Krishnamachari, Q Zhang, ... Tissue Engineering Part A 18 (7-8), 775-784, 2012 | 33 | 2012 |
| Peptide oligomerization memory effects and their impact on the physical stability of the GLP-1 agonist liraglutide JR Bothe, A Andrews, KJ Smith, LA Joyce, Y Krishnamachari, S Kashi Molecular Pharmaceutics 16 (5), 2153-2161, 2019 | 21 | 2019 |
| Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design N Mathias, S Huille, M Picci, RP Mahoney, RJ Pettis, B Case, B Helk, ... Advanced Drug Delivery Reviews, 115301, 2024 | 9 | 2024 |
| Pharmaceutical formulations D Verma, Y Krishnamachari, X Shen, H Lee, P Li, R Singh, LC Tan US Patent App. 15/452,239, 2017 | 7 | 2017 |
| Pharmaceutical formulations D Verma, Y Krishnamachari, X Shen, H Lee, P Li, R Singh, LC Tan US Patent App. 15/179,190, 2016 | 7 | 2016 |
| The impact of syringe age prior to filling on migration of subvisible silicone-oil particles into drug product J Song, G Hu, H Hamzaoui, Y Krishnamachari, SC Persak, H Xi, Y Su Journal of Pharmaceutical Sciences 111 (12), 3191-3194, 2022 | 6 | 2022 |
| Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido) phenyl)-1-isopropyl-1H-pyrazol-4 … D Verma, Y Krishnamachari, X Shen, H Lee, P Li, R Singh, LC Tan US Patent 9,763,941, 2017 | 6 | 2017 |
| Variables impacting silicone oil migration and biologics in prefilled syringes K Gentile, C Huang, X Liu, L Whitty-Léveillé, H Hamzaoui, E Cristofolli, ... Journal of Pharmaceutical Sciences 112 (8), 2203-2211, 2023 | 5 | 2023 |
| Learning Relationships Between Chemical and Physical Stability for Peptide Drug Development J Fine, PR Wijewardhane, SDB Mohideen, K Smith, JR Bothe, ... Pharmaceutical Research 40 (3), 701-710, 2023 | 5 | 2023 |
| Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido) phenyl)-1-isopropyl-1H-pyrazol-4-yl) pyrimidin-2-yl) amino) propan-2-yl) carbamate D Verma, Y Krishnamachari, X Shen, H Lee, P Li, R Singh, LC Tan US Patent 10,561,654, 2020 | 5 | 2020 |
| Characterization of large volume subcutaneous injections using computed tomography imaging and simultaneous pressure measurements M Purcell, S Babaee, M Galluppi, J Cline, G Hu, I Petrescu, J Hughes, ... Frontiers in Drug Delivery 3, 1223177, 2023 | 4 | 2023 |
| Effect of combined locally delivered growth factors and systemic sildenafil citrate on microrecanalization in biodegradable conduit for vas deferens reconstruction HM Rosevear, Y Krishnamachari, CA Ariza, SK Mallapragada, AK Salem, ... Urology 79 (4), 967. e1-967. e4, 2012 | 4 | 2012 |
| Co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies V Antochshuk, PG Desai, Y Krishnamachari, SS Sangani US Patent App. 17/291,701, 2022 | 3 | 2022 |
| Biodegradable particulate formulations AK Salem, SM Geary, GJ Weiner, C Lemke, Y Krishnamachari US Patent 9,572,894, 2017 | 3 | 2017 |
